Immunovant, Inc. (IMVT) Tops Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts IMVT Hot Sheet
Join SI Premium – FREE
Immunovant, Inc. (NASDAQ: IMVT) reported Q3 EPS of ($0.36), $0.07 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .
For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- XP Inc eyes US banking license as next business step
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
